Skip to main content

Advertisement

Table 7 Plasma Creatine

From: Effects of acute ingestion of a pre-workout dietary supplement with and without p-synephrine on resting energy expenditure, cognitive function and exercise performance

Variable Treatment Time (h) p-level
0 1 2
Plasma Creatine PLA 0.74 ± 0.27 0.69 ± 0.21 0.71 ± 0.24 <0.001
(μmol/L) PWS 0.71 ± 0.19 3.13 ± 1.43 *a 3.10 ± 1.45 *a  
PWS + S 0.68 ± 0.17 3.28 ± 1.13 *a 3.89 ± 1.61 *a,b  
  1. Values are means ± standard deviations. MANOVA analysis revealed Wilks’ Lambda treatment (p < 0.001), time (p < 0.001) and treatment x time effects (p < 0.001). The Greenhouse-Geisser univariate treatment x time interaction is reported above. * represents p < 0.05 difference from baseline. a denotes a significant difference from PLA. b denotes a significant difference from PWS. c denotes a significant difference from PWS + S